Biocompatibility of the Composite Scaffold of Sol-Gel Bioactive Glass/Collagen

doi:10.3724/SP.J.1077.2011.00869

Abstract

Abstract: Biomimetic scaffold for bone tissue engineering was prepared by mixing Sol-Gel bioactive glass with type I collagen through freeze-drying technique. In vitro, the biocompatibility of the scaffold was investigated by observing the adhesive, proliferative and differential behaviors of the rat mesenchymal stem cells (rMSCs). In vivo, the composite scaffold seeded with osteoblasts was implanted subcutaneously into the immunodeficient mice for 6w. It was proved that the composite scaffold was non-cytotoxic and suitable for cells’ proliferation, which was confirmed by the increase of double stranded DNA (ds DNA). The differentiation of rMSCs on the composite scaffold was also observed by positive expressions of alkaline phosphatase (ALP) and osteocalcin after osteoinduction for 14d. The results of general and histological observation showed that cells successfully spread on the surface and migrated into the interior of the scaffold. Moreover, bone formation analysis of cell-scaffold constructs in vivo showed that bone tissue and blood vessels were regenerated both inside and on the border of the scaffold-stack. All results demonstrate the Sol-Gel bioactive glass-type I collagen scaffold with good biocompatibility and osteogenesis is a new ideal scaffold for bone tissue repair and regeneration.

Key words: bioglass, mesenchymal stem cell, collagen, biocompatibility

CLC Number:

R318

HAN Xue, CHEN Xiao-Feng, MENG Yong-Chun, ZHOU Jia-An, LIN Cai, JIANG Xiao-Rui, ZHANG Xin-Xin. Biocompatibility of the Composite Scaffold of Sol-Gel Bioactive Glass/Collagen[J]. Journal of Inorganic Materials, 2011, 26(8): 869-873.

References

[1] Zhang Y, Reddy V J, Wong S Y, et al. Enhanced biomineralization in osteoblasts on a novel electrospun biocomposite nanofibrous substrate of hydroxyapatite/collagen/chitosan. Tissue Engineering Part A, 2010, 16(6): 1949-1960.

[2] Madurantakam P A, Cost C P, Simpson D G, et al. Science of nanofibrous scaffold fabrication: strategies for next generation tissue- engineering scaffolds. Nanomedicine, 2009, 4(2): 193-206.

[3] 田卫东, 李邓, 陈高. 胶原与羟基磷灰石复合人工骨的实验研究. 中国口腔种植学杂志, 1999, 4(1): 7-11.

[4] Hattar S, Loty S, Gaisser D, et al. Effects of 58s Sol-Gel glasses on the temporal expression of bone markers during mouse osteoblastic differentiation. Journal of Biomedical Materials Research Part A, 2006, 76A(4): 811-819.

[5] 张娟娟, 孟永春, 陈晓峰, 等. 溶胶-凝胶生物活性玻璃/胶原复合多孔支架的力学性能研究. 医用生物力学, 2010, 25(1): 16-20.

[6] Prasad B R, Brook M A, Smith T, et al. Controlling cellular activity by manipulating silicone surface roughness. Colloids and Surfaces B-Biointerfaces, 2010, 78(2): 237-242.

[7] Aronin C E P, Sadik K W, Lay A L, et al. Comparative effects of scaffold pore size, pore volume, and total void volume on cranial bone healing patterns using microsphere-based scaffolds. Journal of Biomedical Materials Research Part A, 2009, 89A(3): 632-641.

[8] Hu J, Feng K, Liu X H, et al. Chondrogenic and osteogenic differentiations of human bone marrow-derived mesenchymal stem cells on a nanofibrous scaffold with designed pore network. Biomaterials, 2009, 30(28): 5061-5067.

[9] Gong Z, Xiong H, Long X, et al. Use of synovium-derived stromal cells and chitosan/collagen type I scaffolds for cartilage tissue engineering. Biomedical Materials, 5(5): 055005.

[10] Brodbeck W G, Patel J, Voskerician G, et al. Biomaterial adherent macrophage apoptosis is increased by hydrophilic and anionic substrates in vivo. Proceedings of the National Academy of Sciences of the United States of America, 2002, 99(16): 10287-10292.

[11] Heath D E, Cooper S L. Design and characterization of PEGylated terpolymer biomaterials. Journal of Biomedical Materials Research Part A, 2010, 94A(4): 1294-1302.

[12] Thibault R A, Baggett L S, Mikos A G, et al. Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements. Tissue Engineering Part A, 2010, 16(2): 431-440.

[13] Xu C X, Wang Y J, Yu X B, et al. Evaluation of human mesenchymal stem cells response to biomimetic bioglass-collagen- hyaluronic acid-phosphatidylserine composite scaffolds for bone tissue engineering. Journal of Biomedical Materials Research Part A, 2009, 88A(1): 264-273.

[14] Ripamonti U. Biomimetism, biomimetic matrices and the induction of bone formation. Journal of Cellular and Molecular Medicine, 2009, 13(9B): 2953-2972.

[15] Hench L L, Polak J M. Third-generation biomedical materials. Science, 2002, 295(5557): 1014-1017.

[16] Olmo N, Martin A I, Salinas A J, et al. Bioactive Sol-Gel glasses with and without a hydroxycarbonate apatite layer as substrates for osteoblast cell adhesion and proliferation. Biomaterials, 2003, 24(20): 3383-3393.

[17] Yue Z, Wen F, Gao S, et al. Preparation of three-dimensional interconnected macroporous cellulosic hydrogels for soft tissue engineering. Biomaterials, 2010, 31(32): 8141-8152.

[18] Bruder S P, Kraus K H, Goldberg V M, et al. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. Journal of Bone and Joint Surgery-American Volume, 1998, 80A(7): 985-996.

[19] 朱六龙, 戴克戎, 汤亭亭, 等. 骨形成蛋白-2基因转染人骨髓间质干细胞诱导异位成骨的实验研究. 中国修复重建外科杂志, 2003, 17(2): 131-135.

[20] Zhang X, Xie C, Lin A, et al. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. Journal of Bone and Mineral Research, 2005, 20(12): 2124-2137.

[21] Viateau V, Guillemin G, Bousson V, et al. Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep. Journal of Orthopaedic Research, 2007, 25(6): 741-749.